Effect of MD1003 (high dose pharmaceutical grade biotin) on remotely monitored ambulatory activity in progressive MS: initial step count data of the phase 3 SPI2 study
MULTIPLE SCLEROSIS JOURNAL（2018）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要